(Q44099099)

29 November 2017

title

Plasma YKL-40 predicts 10-year cardiovascular and all-cause mortality in individuals with type 2 diabetes (English)

1 reference

29 November 2017

1 reference

1 reference

2

1 reference

29 November 2017

Chih-Hung Lin

1

1 reference

29 November 2017

Yi-Der Jiang

series ordinal

3

1 reference

29 November 2017

Tien-Jyun Chang

series ordinal

4

1 reference

29 November 2017

Lee-Ming Chuang

series ordinal

5

1 reference

29 November 2017

publication date

25 March 2013

1 reference

29 November 2017

published in

Clinical Endocrinology

1 reference

29 November 2017

volume

79

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

185-191

1 reference

Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation

29 November 2017

cites work

1 reference

YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis

21 January 2018

1 reference

Serum YKL-40 levels in patients with coronary artery disease.

21 January 2018

1 reference

YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria

21 January 2018

1 reference

YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance.

21 January 2018

1 reference

Plasma YKL-40: a BMI-independent marker of type 2 diabetes

21 January 2018

1 reference

Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

21 January 2018

1 reference

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people

21 January 2018

1 reference

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

Standards of medical care in diabetes--2011.

21 January 2018

1 reference

Cardiovascular disease risk profiles.

21 January 2018

1 reference

Medical treatment of peripheral arterial disease and claudication

21 January 2018

1 reference

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population

21 January 2018

1 reference

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

Serum YKL-40, a new prognostic biomarker in cancer patients?

21 January 2018

1 reference

The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha

21 January 2018

1 reference

YKL-40 levels are independently associated with albuminuria in type 2 diabetes

21 January 2018

1 reference

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12015

1 reference

29 November 2017

1 reference